You are here

Program Directors

Program Directors

Program Directors oversee the research activities in one or more parts of the Institute's research funding program, managing a portfolio of grants and contracts and coordinating program efforts in these specifically defined areas of neuroscience research. Please reach out to individual Program Directors for more information about specific opportunities.

Bioengineering
Brain and Spinal Cord Injury
Brain Cancer
Channels, Synapses, and Circuits
CNS Infection/Neurovirology
Cognitive Neuroscience
Computational Neuroscience
Epidemiology/Biostatistics
Epilepsy & Epileptogenesis
Genetic and Developmental Research
Lysosomal Storage Disorders
Movement Disorders
Multiple Sclerosis
NeuroAIDS
Neurodegeneration
Neuroethics
Neuroprotection
Pain
Pediatric Neurology
Programs to Enhance Neuroscience Workforce Diversity (OPEN-WD)
Regeneration
Rehabilitation
Stem Cells
Stroke
Systems Neuroscience
Translational Research

Bioengineering

Jim Gnadt – Sensory systems, neuroendocrine systems, thalamo-cortical functions, computational neuroscience, prosthetics control systems
Nick Langhals – Neural engineering with emphases in neuroprostheses, neuromodulation, brain-computer interface (BCI) devices, prosthetic control, and neural interface technology development
Daofen Chen – Motor systems, Neuroprosthetic and Robotic applications, Rehab engineering, Clinical studies and Behavioral interventions for stroke and cerebral palsy, Rehabilitation, Sensorimotor learning and Executive functions

Brain and Spinal Cord Injury

Patrick Bellgowan – Basic, translational and clinical studies of traumatic brain injury
Scott Janis – Clinical trials and epidemiology, Cerebrovascular disease, Traumatic Brain Injury (TBI), NINDS Stroke Trials Network and the Neurological Emergencies Treatment Trials Network (NETT)
Lyn Jakeman – Spinal cord injury, peripheral nerve injury and regeneration
Daofen Chen – Motor systems, Neuroprosthetic and Robotic applications, Rehab engineering, Clinical studies and Behavioral interventions for stroke and cerebral palsy, Rehabilitation, Sensorimotor learning and Executive functions
Francesca Bosetti – Stroke, neuroinflammation, glial cell biology, neuroprotection, repair and recovery
Jim Koenig – Hemorrhagic stroke, neurodevelopmental hypoxia-ischemia and pediatric stroke, neurovascular biology and pathophysiology, cerebral blood flow, neuroimaging and genetics/epigenetic mechanisms

Brain Cancer

Jane Fountain – Brain Tumors, Tuberous Sclerosis, Glial Biology

Channels, Synapses and Circuits

Steven B. Churn – Synaptic plasticity, including learning and memory, homeostatic plasticity, and aging
Miriam Leenders - Basic structure of channels, structural biology, proteomics
Daniel Miller – Invertebrate NMJ synaptic development, structure and function
Shai Silberberg – Channels, transporters and pumps, channelopathy
Ned Talley – Basic research in synaptic transmission, optical technologies for recording and manipulating circuits, technologies for tracing and accessing circuits

CNS Infection/Neurovirology

May Wong – HIV-associated neurological disorders, infectious diseases of the nervous system, neurovirology, and Creutzfeldt-Jacob Disease and other transmissible spongiform encephalopathies

Cognitive Neuroscience

Deb Babcock – Behavioral and cognitive neuroscience, neuroimaging, CNS plasticity, Lewy Body Dementia (LBD)
Patrick Bellgowan – Cognitive/emotional domains affected by TBI
Claudia Moy – Epidemiology and Clinical studies in cognition, Aneurysm
Daofen Chen – Motor systems, Neuroprosthetic and Robotic applications, Rehab engineering, Clinical studies and Behavioral interventions for stroke and cerebral palsy, Rehabilitation, Sensorimotor learning and Executive functions

Computational Neuroscience

Jim Gnadt – Sensory systems, neuroendocrine systems, thalamo-cortical functions, computational neuroscience, prosthetics control systems

Epidemiology/Biostatistics

Peter Gilbert – Biostatistics and clinical trial design
Claudia Moy – Epidemiology and Clinical studies in cognition, Aneurysm

Epilepsy & Epileptogenesis

Steven B. Churn – Circuit mechanisms and seizure initiation in acquired epilepsies; comorbidities and co-occurring conditions, including cognitive impairments, intellectual disabilities, memory, aging, and Alzheimer's Disease & Related Dementias
Adam Hartman – Pediatric epilepsy; clinical epilepsy research
Miriam Leenders – The role of neurogenesis, neuroinflammation and infection in acquired epilepsies; Lafora Disease; comorbidities and co-occurring conditions, including psychiatric and hormonal (stress, reproductive)
Vicky Whittemore – Genetic epilepsies; metabolic epilepsy and ketogenic diet; clinical epilepsy research; SUDEP; seizure prediction

Genetic and Developmental Research

Laura Mamounas – signal transduction in development and plasticity, autism spectrum disorders, Fragile X, Rett Syndrome, tuberous sclerosis complex
Jill Morris – Mid-/hind-brain development/malformations, hydrocephalus, Spina Bifida, Tourette syndrome
Glen Nuckolls – Muscular dystrophies, spinal muscular atrophy, inherited neuropathies
Robert Riddle – Developmental neuroscience, Down Syndrome
Tim Lavaute – Neurogenesis and progenitor cell biology in nervous system development and function, application/treatment, tissue engineering

Lysosomal Storage Disorders

Jill Morris – Mid-/hind-brain development/malformations, hydrocephalus, Spina Bifida, Tourette syndrome

Movement Disorders

Codrin Lungu – Parkinson's disease, dystonia, tremor, myoclonus
Beth-Anne Sieber – Movement Disorders

Multiple Sclerosis

Ursula Utz – Neuroimmunology, Autoimmunity, Neurovirology, Multiple Sclerosis

NeuroAIDS

May Wong – HIV-associated neurological disorders, infectious diseases of the nervous system, neurovirology, and Creutzfeldt-Jacob Disease and other transmissible spongiform encephalopathies

Neurodegeneration

Deb Babcock – Behavioral and cognitive neuroscience, neuroimaging, CNS plasticity, Lewy Body Dementia (LBD)
Robin Conwit – Amyotrophic Lateral Sclerosis (ALS) clinical trials
Roderick Corriveau – Alzheimer’s disease (AD), Vascular contributions to cognitive impairment and dementia (VCID), CADASIL, Basic research related to neurodegeneration in the areas of protein folding, Protein trafficking, cytoskeleton, synapses, and synaptic receptors
Amelie Gubitz – Amyotrophic Lateral Sclerosis (ALS), spinal and bulbar muscular atrophy, hereditary spastic paraplegia, Friedreich’s ataxia
Codrin Lungu – Parkinson's disease, dystonia, tremor, myoclonus
Linda McGavern – Alzheimer’s Disease (AD)
Daniel Miller – Invertebrate NMJ synaptic development, structure and function
Beth-Anne Sieber – Parkinson’s disease (molecular genetics, DBS)

Neuroethics

Khara Ramos – Neuroethics, bioethics

Neuroprotection

Francesca Bosetti – Stroke, neuroinflammation, glial cell biology, neuroprotection, repair and recovery
Jim Koenig – Hemorrhagic stroke, neurodevelopmental hypoxia-ischemia and pediatric stroke, neurovascular biology and pathophysiology, cerebral blood flow, neuroimaging and genetics/epigenetic mechanisms

Pain

Michael L. Oshinsky – Central and peripheral mechanisms of pain, pain chronification, migraine and other headache disorders.

Pediatric Neurology

Adam Hartman – Pediatric Epilepsy; Clinical Epilepsy Research
Jim Koenig – Hemorrhagic stroke, neurodevelopmental hypoxia-ischemia and pediatric stroke, neurovascular biology and pathophysiology, cerebral blood flow, neuroimaging and genetics/epigenetic mechanisms
Daofen Chen – Motor systems, Neuroprosthetic and Robotic applications, Rehab engineering, Clinical studies and Behavioral interventions for stroke and cerebral palsy, Rehabilitation, Sensorimotor learning and Executive functions

Programs to Enhance Neuroscience Workforce Diversity (OPEN-WD)

Michelle Jones-London – Chief, Office of Programs to Enhance Neuroscience Workforce Diversity
Marguerite Matthews – Diversity F31, Research Supplements to Support Diversity and Re-entry in Biomedical Research, SCORE (SC1 and SC2) awards, ENDURE and Diversity R25 awards
Lauren Ullrich – Diversity K22, Diversity Faculty K01, D-SPAN F99/K00, Summer R25s

Regeneration

Lyn Jakeman – Spinal cord injury, peripheral nerve injury and regeneration
Nick Langhals – Neural engineering with emphases in neuroprostheses, neuromodulation, brain-computer interface (BCI) devices, prosthetic control, and neural interface technology development
Timothy Lavaute – Neurogenesis and progenitor cell biology in nervous system development and function, application/treatment, tissue engineering

Rehabilitation

Daofen Chen – Motor systems, Neuroprosthetic and Robotic applications, Rehab engineering, Clinical studies and Behavioral interventions for stroke and cerebral palsy, Rehabilitation, Sensorimotor learning and Executive functions
Lyn Jakeman – Spinal cord injury, peripheral nerve injury and regeneration
Scott Janis – Clinical trials and epidemiology, Cerebrovascular disease, Traumatic Brain Injury (TBI), NINDS Stroke Trials Network and the Neurological Emergencies Treatment Trials Network (NETT)

Stem Cells

Timothy Lavaute – Neurogenesis and progenitor cell biology in nervous system development and function, application/treatment, tissue engineering

Stroke

Francesca Bosetti – Stroke, neuroinflammation, glial cell biology, neuroprotection, repair and recovery
Scott Janis – Clinical trials and epidemiology, Cerebrovascular disease, Traumatic Brain Injury (TBI), NINDS Stroke Trials Network and the Neurological Emergencies Treatment Trials Network (NETT)
Jim Koenig – Hemorrhagic stroke, neurodevelopmental hypoxia-ischemia and pediatric stroke, neurovascular biology and pathophysiology, cerebral blood flow, neuroimaging and genetics/epigenetic mechanisms
Claudia Moy – Epidemiology and Clinical studies in cognition, Aneurysm
Daofen Chen – Motor systems, Neuroprosthetic and Robotic applications, Rehab engineering, Clinical studies and Behavioral interventions for stroke and cerebral palsy, Rehabilitation, Sensorimotor learning and Executive functions
Roderick Corriveau – Alzheimer’s disease (AD), Vascular contributions to cognitive impairment and dementia (VCID), CADASIL, Basic research related to neurodegeneration in the areas of protein folding, Protein trafficking, cytoskeleton, synapses, and synaptic receptors

Systems Neuroscience

Jim Gnadt – Sensory systems, Neuroendocrine systems, Thalamo-cortical functions, Computational neuroscience, Prosthetics control systems
Janet He – Sleep, Circadian Rhythms, Feeding and Body Weight, Sleep in Neurological Disorders, Neurobiology of Obesity and Sleep Disordered Breathing
Daofen Chen – Motor systems, Neuroprosthetic and Robotic applications, Rehab engineering, Clinical studies and Behavioral interventions for stroke and cerebral palsy, Rehabilitation, Sensorimotor learning and Executive functions
Karen David – Integrative function of brain circuits, sensorimotor integration, multi-sensory processing

Translational Research

Stephanie Fertig – Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs, Cooperative Research to Enable and Advance Translational Enterprises: Therapeutic Devices Small Business Programs (SBIR/STTR), Translational Devices
Mohamed Hachicha – Blueprint Neurotherapeutic Network (BPN), preclinical neurotherapeutic small molecule development
John Kehne – Epilepsy Therapy Screening Program (ETSP), preclinical pharmacology, animal models. preclinical neurotherapeutic development
Brian Klein – Epilepsy Therapy Screening Program (ETSP), preclinical pharmacology, animal models. preclinical neurotherapeutic development
Pascal Laeng – Blueprint Neurotherapeutic Network (BPN), preclinical neurotherapeutic small molecule development, high throughput screening
Mary Ann Pelleymounter – Innovation Grants to Nurture Initial Translational Efforts (IGNITE), Blueprint Neurotherapeutic Network (BPN), preclinical pharmacology, animal models, systems biology, pharmacodynamic markers, preclinical neurotherapeutic development
Shamsi Raeissi – Epilepsy Therapy Screening Program (ETSP), preclinical pharmacology, animal models. preclinical neurotherapeutic development
David Jett – NIH Counterterrorism (CounterACT) program, neurotoxicology
Chris Boshoff – Cooperative Research to enable and Advance Translational Enterprises (CREATE), preclinical neurotherapeutic biologics development

Date last modified: Wed, 2019-12-04 18:32